IP Library Assignment 054687/0137
Patent Assignment
Reel/Frame 054687/0137

Assignment of Assignor's Interest

Recorded: 2020-12-17 Pages: 7
Assignor
EXXPHARMA THERAPEUTICS LLC
Executed: 2020-12-07
Assignee
NEUROCRINE BIOSCIENCES, INC.
12780 EL CAMINO REAL, SAN DIEGO, CALIFORNIA, 92130
Covered Properties (5)
Continuous Melt Spheronization Apparatus and Process for the Production of Pharmaceutical Pellets
Patent: 7,771,632 →
Application: 11/434,041 →
Publication: US 2007/0264328
Process for Enhancing the Solubility of Poorly Soluble Drugs
Patent: 7,607,596 →
Application: 12/072,224 →
Tamper-Resistant Pharmaceutical Dosage Forms
Patent: 9,770,514 →
Application: 14/157,658 →
Publication: US 2015/0064250
Tamper-Resistant Pharmaceutical Dosage Forms and Process for Making Same
Application: 15/058,955 →
Publication: US 2016/0175454
Novel Bioavailability Enhancement Composition
Application: 16/032,256 →
Publication: US 2019/0015326
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 8, 2006
From: GHEBRE-SELLASSIE, ISAAC; MARTIN, CHARLES; ELLIOT, BERT
To: AMERICAN LEISTRITZ EXTRUDER CORP.; PHARMACEUTICAL TECHNOLOGY SOLUTIONS, LLC
Reel/Frame 018067/0834 →
Assignment of Assignor's Interest Feb 25, 2008
From: GHEBRE-SELLASSIE, ISAAC; TEREFE, HIBRENIGUS
To: PHARMACEUTICAL TECHNOLOGY SOLUTIONS, LLC
Reel/Frame 020613/0782 →
Assignment of Assignor's Interest Jul 18, 2008
From: PHARMACEUTICAL TECHNOLOGY SOLUTIONHS, LLC
To: EXXPHARMA, LLC
Reel/Frame 021280/0562 →
Assignment of Assignor's Interest Jan 17, 2014
From: GHEBRE-SELLASSIE, ISAAC; TEREFE, HIBRENIGUSS
To: EXXPHARMA THERAPEUTICS LLC
Reel/Frame 031992/0139 →
Assignment of Assignor's Interest Mar 7, 2016
From: GHEBRE-SELLASSIE, ISAAC; TEREFE, HIBRENIGUSS
To: EXXPHARMA THERAPEUTICS LLC
Reel/Frame 037912/0428 →
Assignment of Assignor's Interest Jul 26, 2018
From: GHEBRE-SELLASSIE, ISAAC; TEREFE, HIBRENIGUSS
To: EXXPHARMA THERAPEUTICS LLC
Reel/Frame 046475/0611 →
Confirmatory Grant of Security Interest in United States Patents May 26, 2026
From: NEUROCRINE BIOSCIENCES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075670/0001 →